Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Q2 FY27 Results: Net Profit ₹10.2 Cr, Up 0.0% YoY

Jenburkt Pharmaceuticals posted Q2 revenue of Rs. 4,831.82 lakhs and PAT of Rs. 1,020.94 lakhs. Results were approved on 3 November 2026.

Key figure

Net profit ₹10.2 Cr · +0.0% YoY

Jenburkt Pharmaceuticals Q1 FY27 Results: Net Profit ₹5.9 Cr, Down 24.4% YoY

Jenburkt Pharmaceuticals Ltd reported revenue from operations of ₹35.5 Cr (+0.0% YoY) and net profit of ₹5.9 Cr (-24.4% YoY) for Q1 FY27.

Key figure

Net profit ₹5.9 Cr · -24.4% YoY

Jenburkt Pharmaceuticals Q4 FY26 Results: Net Profit ₹34.7 Cr, Up 8.1% YoY

Jenburkt Pharmaceuticals Ltd reported revenue from operations of ₹168.7 Cr (+11.2% YoY) and net profit of ₹34.7 Cr (+8.1% YoY) for Q4 FY26.

Key figure

Net profit ₹34.7 Cr · +8.1% YoY

Jenburkt Pharmaceuticals Q4 FY26 Results: Net Profit ₹10.8 Cr, Up 27.1% YoY

Jenburkt Pharmaceuticals Ltd reported revenue from operations of ₹44.6 Cr (+8.8% YoY) and net profit of ₹10.8 Cr (+27.1% YoY) for Q4 FY26.

Key figure

Net profit ₹10.8 Cr · +27.1% YoY

Jenburkt Pharmaceuticals Financial Results

Jenburkt Pharmaceuticals Limited reported its audited financial results for FY 2025-26, alongside a recommended dividend of ₹20.70 (207%) per equity share. The Board also approved the re-appointment of Shri Dilip H. Bhuta as Whole time Director and CFO for a five-year term starting April 2027.